First American COVID-19 vaccine recipient gets booster shot on Long Island

LONG ISLAND - Intensive care unit nurse Sandra Lindsay, the first person in the United States to receive a COVID-19 vaccine, got her booster shot at New York’s Northwell Long Island Jewish Medical Center on October 6.

New York Gov Kathy Hochul announced a booster rollout plan for the state on September 27.

"A booster dose of the COVID-19 vaccine will help particularly at-risk New Yorkers stay protected from the virus for longer," Hochul said in a press release. "While the focus of our vaccination effort remains ensuring all unvaccinated New Yorkers get vaccinated, those who are booster eligible should waste no time receiving maximum protection from COVID-19 as soon as possible."

This video provided by Michael H Goldberg shows Lindsay receiving the booster shot.

Get breaking news alerts in the free FOX5NY News app!  |  Sign up for FOX 5 email newsletters

Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.

J&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine. While the company said it submitted data on several different booster intervals, ranging from two to six months, it did not formally recommend one to regulators.

Last month, the FDA authorized booster shots of Pfizer’s vaccine for older Americans and other groups with heightened vulnerability to COVID-19. It’s part of a sweeping effort by the Biden administration to shore up protection amid the delta variant and potential waning vaccine immunity.

Government advisers backed the extra Pfizer shots, but they also worried about creating confusion for tens of millions of other Americans who received the Moderna and J&J shots. U.S. officials don't recommend mixing and matching different vaccine brands.

The FDA is convening its outside panel of advisers next week to review booster data from both J&J and Moderna. It’s the first step in a review process that also includes sign-off from the leadership of both the FDA and the Centers for Disease Control and Prevention. If both agencies give the go-ahead, Americans could begin getting J&J and Moderna boosters later this month.

J&J previously released data suggesting its vaccine remains highly effective against COVID-19 at least five months after vaccination, demonstrating 81% effectiveness against hospitalizations in the U.S.

But company research shows a booster dose at either two or six months revved up immunity even further. Data released last month showed giving a booster at two months provided 94% protection against moderate-to-severe COVID-19 infection. The company has not yet released clinical data on a six-month booster shot.

FDA's advisers will review studies from the company and other researchers next Friday and vote on whether to recommend boosters.